Navigation Links
Top 10 Drug Delivery Technologies (2010 - 2015): MarketsandMarkets
Date:6/21/2010

DALLAS, Texas, June 21, 2010 /PRNewswire/ -- The Pharmaceutical practice at MarketsandMarkets is pleased to announce a new report titled Top 10 Drug Delivery Technologies (2010 - 2015).

Browse in-depth TOC on Top 10 Drug Delivery Technologies (2010 - 2015)

Early buyers will receive 10% customization of reports http://www.marketsandmarkets.com/Market-Reports/top-10-drug-delivery-technolo gies-112.html

(Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.)

More than 25% of the marketed drugs fail to provide expected commercial returns due to drug distribution and absorption levels within the body (pharmacokinetics) therefore signifying the importance of drug delivery systems. Rapid enhancements in drug discovery technologies have lead to developments in proteomics and genomics and had a greater impact on drug delivery technology market. The changing market trends, with quick cycle of innovations have compelled market participants to clearly understand changing dynamics and focus on emerging technology and enhance market positions in terms of revenues, growth and geographical presence.

    STUDY GOALS AND OBJECTIVES

    - To define and measure drug delivery market and its various
      sub-segments with respect to types of systems, by mode of drug
      delivery, by therapeutics and others.
    - To identify major drivers and restraints of the market
    - To evaluate comprehensively all drug delivery technologies and
      benchmark them against various parameters to identify top ten
      technologies.
    - To identify and analyze comprehensively market structure with
      respect to the factors influencing market growth and industry specific
      challenges.
    - To analyze trends and forecasts of drug delivery market and its
      segments
    - To identify major stakeholders in the market and draw a
      competitive landscape for market leaders for each of the drug delivery
      technology market.
    - To analyze opportunities in the market for stakeholders
    - To strategically analyze micro markets with respect to their
      individual growth trends, future prospects and contribution to the
      total market
    - To understand regulatory framework, design criteria, pricing
      issues, threat from alternative methods available in the market.
    - To analyze and forecast revenues of market segments with respect
      to geographies (North America, Europe, Asia and Rest of the World
    - To provide comprehensive analysis of top players in the drug
      delivery technology market.
    - To effectively scope out and justify evaluation and provide
      sufficient basis of ranking top ten drug delivery technologies.

SCOPE AND FORMAT

The report intensively evaluates drug delivery technologies with respect to revenues, growth, therapeutic areas, patents registered and industry focus to arrive at top 10 drug delivery technologies. The key drug delivery technologies discussed in the report are:

    - Oral drug delivery technologies
    - Injectable drug delivery technologies
    - Pulmonary drug delivery technologies
    - Transdermal drug delivery technologies
    - Other drug delivery technologies

The report also focuses on the emerging drug delivery technologies and mechanisms.

    INTENDED AUDIENCES

    - Drug delivery technology - manufacturers, suppliers and dealers
    - Pharmaceutical and biotech companies
    - Healthcare providers
    - Potential investors in the drug delivery technology market

INFORMATION SOURCES

Each of the section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report will also provide market tables for various geographic regions covering sub segments and micro markets. In addition the report also provides 40 companies. Key market developments will be sourced from the top companies that are profiled. Secondary research will progress through both paid and unpaid sources. We will conduct primary research to provide in-depth understanding of the market.

About MarketsandMarkets

MarketsandMarkets (M&M) is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.

M&M covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website http://www.marketsandmarkets.com

    Contact:
    Ms. Sunita
    7557 Rambler road,
    Suite 727, Dallas, TX 75231
    Tel: +1-888-989-8004
    Email: sales@marketsandmarkets.com
    http://www.marketsandmarkets.com


'/>"/>
SOURCE MarketsandMarkets
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug
2. Carrington Subsidiary DelSite Biotechnologies Enters into Technology Evaluation Rights License Agreement for Transdermal Delivery of Vaccines
3. Valeritas Hires Trade and Distribution Industry Expert for the Launch of the h-Patch(TM) Disposable Insulin Delivery Device
4. Valeritas Hires Senior Account Management Industry Expert for the Launch of the h-Patch(TM) Disposable Insulin Delivery Device
5. Baxter and Novation Sign Multi-Year Contract Extension Valued at Over $200 Million for Medication Delivery Products
6. Sigma-Aldrich Introduces N-TER Nanoparticle siRNA Transfection System for Delivery of siRNA Into Difficult-to-Transfect Cell Types
7. Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp. of Washington
8. BAI Retail Delivery Conference Softpro Presents Next Generation Signature Tablet
9. Cell Genesys Announces Sale of Lentiviral Gene Delivery Technology for $12 Million
10. Clinical and Economical Considerations For IV Push Drug Delivery by Industry Expert Richard Rosenfeld Is Now Accessible on Expert411.com for Media and Professional Use
11. Edwards Lifesciences Receives FDA Approval to Add Transapical Delivery System to U.S. Clinical Trial of Transcatheter Heart Valve
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... IsoPlexis ... against cancer, autoimmune disease and more through a single-cell precision engineering platform, today ... analysis platform developed in the laboratory of Dr. James Heath at the ...
(Date:3/27/2017)... 2017  Perthera,s Chief Bioinformatics Officer and research faculty ... , Ph.D., will be speaking at the American Medical ... March 27, 2017, she will be speaking on the ... Research and Care" (from 10:30 a.m. – 12:00 p.m. ... be a participant in the "Making Precision Oncology Data ...
(Date:3/27/2017)... , March 27, 2017 DarioHealth Corp. ... mobile health and big data solutions, today announced that ... insurance coverage option for U.S. consumers who want to ... DarioHealth has signed strategic alliance agreements with partners ... insurance coverage benefits, and if approved, will supply and ...
(Date:3/24/2017)... March 24, 2017 Sinovac Biotech Ltd. ("Sinovac" or the ... China , today announced that its board of directors ... of the plan from March 27, 2017 to March 27, 2018. The ... About Sinovac Biotech Ltd. ... Sinovac Biotech Ltd. is a ...
Breaking Biology Technology:
(Date:3/1/2017)... Mass. , March 1, 2017  Aware, Inc. ... services, announced that Richard P. Moberg has ... and co-President and Chief Financial Officer and Treasurer of ... continue to serve as a member of the Board ... Russell , Aware,s co-Chief Executive Officer and co-President, General ...
(Date:2/27/2017)... 2017   Strategic Cyber Ventures , the industry,s ... a $3.5 million investment in  Polarity , the first ... is DC based and is led by cybersecurity veterans ... Ron Gula , also a longtime cybersecurity veteran ... this series A round of funding. This new funding ...
(Date:2/21/2017)... and PORTLAND, Ore. , Feb. ... the Avamere Family of Companies (Avamere Health Services, Infinity ... a six-month research study that will apply the power ... at senior living and health centers. By analyzing data ... to gain insights into physical and environmental conditions, and ...
Breaking Biology News(10 mins):